ADMA Biologics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADMA Biologics and other ETFs, options, and stocks.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
527
Employees527
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
527
Employees527

ADMA Key Statistics

Market cap
870.94M
Market cap870.94M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.83M
Average volume3.83M
High today
$3.68
High today$3.68
Low today
$3.42
Low today$3.42
Open price
$3.46
Open price$3.46
Volume
4.32M
Volume4.32M
52 Week high
$3.68
52 Week high$3.68
52 Week low
$1.17
52 Week low$1.17

ADMA News

Yahoo Finance 1d
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock - Yahoo Finance

ADMA Biologics, Inc. RAMSEY, N.J. and BOCA RATON, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”), an end-...

ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock - Yahoo Finance
MarketWatch 2d
Stocks to Watch: ADMA Biologics, Uniti Group, Casey's General Stores - MarketWatch

By Sabela Ojea ADMA Biologics Inc. said it is planning an underwritten public offering. The biopharmaceutical company's shares slid 8.2% in U.S. after-hours tr...

Stocks to Watch: ADMA Biologics, Uniti Group, Casey's General Stores - MarketWatch
MarketWatch 2d
ADMA Biologics Shares Fall 9%, Company Plans Underwritten Public Offering - MarketWatch

By Stephen Nakrosis ADMA Biologics Inc. shares were trading lower after hours Tuesday following news the company is planning an underwritten public offering....

ADMA Biologics Shares Fall 9%, Company Plans Underwritten Public Offering - MarketWatch

ADMA Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 23, After Hours
ActualExpected Mar 23, After Hours

More ADMA News

Yahoo Finance 2d
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate - Yahoo Finance

ADMA Biologics, Inc. Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million RAMSEY, N.J. and BOCA RATON, Fla., Dec. 06, 202...

ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.